US Patent 10555899 Long-acting non-aqueous injectable formulations and use thereof
Patent 10555899 was granted and assigned to Piedmont Animal Health on February, 2020 by the United States Patent and Trademark Office.
All edits
Edits on 18 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 11 Dec, 2023
Golden AI
Edits made to:
Article (+198 characters)
Article
Patent abstract
Provided herein are long-acting, non-aqueous pharmaceutically acceptable compositions of active ingredients for subcutaneous injection, in particular analgesics such as buprenorphine.
Edits on 25 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
105558990
Date of Patent
February 11, 2020
0Patent Application Number
160006700
Date Filed
June 5, 2018
0Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
105558990
Date of Patent
February 11, 2020
0Patent Application Number
160006700
Date Filed
June 5, 2018
0Patent Primary Examiner
Edits on 1 Feb, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10555899 Long-acting non-aqueous injectable formulations and use thereof
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10555899
Date of patent
February 11, 2020
Patent application number
16000670
Date Filed
June 5, 2018
Patent primary examiner
Find more entities like US Patent 10555899 Long-acting non-aqueous injectable formulations and use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.